13F HOLDINGS REPORT
Allostery Investments LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001013594-25-001022
Total Value
$7.9M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 167,350 | $1.3M | 16.31% |
| 2 | AKERO THERAPEUTICS INC | 00973Y108 | 22,500 | $1.2M | 15.29% |
| 3 | AMYLYX PHARMACEUTICALS INC | AMLX | 120,119 | $769,963 | 9.81% |
| 4 | CENTESSA PHARMACEUTICALS PLC | CNTA | 52,500 | $689,850 | 8.79% |
| 5 | EVOLUS INC | EOLS | 60,000 | $552,600 | 7.04% |
| 6 | REZOLUTE INC | RZLT | 119,294 | $532,051 | 6.78% |
| 7 | MERUS N V | N5749R100 | 9,000 | $473,400 | 6.03% |
| 8 | KALVISTA PHARMACEUTICALS INC | KALV | 40,000 | $452,200 | 5.76% |
| 9 | FULCRUM THERAPEUTICS INC | FULC | 40,353 | $277,629 | 3.54% |
| 10 | APOGEE THERAPEUTICS INC | APGE | 6,000 | $260,580 | 3.32% |
| 11 | VERONA PHARMA PLC | 925050106 | 2,500 | $236,450 | 3.01% |
| 12 | TANGO THERAPEUTICS INC | TNGX | 40,000 | $204,800 | 2.61% |
| 13 | BRIDGEBIO PHARMA INC | BBIO | 4,000 | $172,720 | 2.20% |
| 14 | CYTOKINETICS INC | CYTK | 5,000 | $165,200 | 2.10% |
| 15 | TOURMALINE BIO INC | 89157D105 | 9,356 | $149,602 | 1.91% |
| 16 | LEGEND BIOTECH CORP | LEGN | 4,000 | $141,960 | 1.81% |
| 17 | NEKTAR THERAPEUTICS | NKTR | 4,000 | $103,360 | 1.32% |
| 18 | PROMIS NEUROSCIENCES INC | PMN | 155,720 | $76,303 | 0.97% |
| 19 | ARCELLX INC | ACLX | 1,000 | $65,850 | 0.84% |
| 20 | AVALO THERAPEUTICS INC | AVTX | 9,000 | $44,910 | 0.57% |